High-speed Ancelus SaaS data system launches
INDIANAPOLIS – Research-ready, super-high-speed data management resources are now available for epidemiologists, pathologists, biologists and other scientific professionals in synthetic chemistry labo
ratories. The cloud-based Series JL5000 Ancelus SaaS data management system can be immediately deployed for professionals engaged in automating combinatorial chemistry efforts.
Synthetic laboratories, epidemiologists and biotech companies conducting combinatorial chemistry for COVID19 research can leverage high-speed Ancelus SaaS-driven automated methods for reaction design, information management, chemical synthesis, compound analysis, and biological testing. Software available for free 90-day trial to qualified companies or institutions to advance no-risk integration.
The high-speed Ancelus software, capable of processing multiple billions of data records in nanoseconds, has the capacity to potentially support the discovery of relevant compounds, and eventually a novel vaccine or pharmaceutical treatment to aid in the COVID19 crisis through a combinatorial process.
In the interest of saving lives and slowing the economic onslaught engulfing the world, the Ancelus SaaS software will be made available free through a 90-day trial plan to qualified synthetic chemistry laboratories, biotech research companies and other related scientific entities, according to John Morris, chief operating officer of Time Compression Strategies, the developer of AncelusDB and the new cloud-based Series JL5000 Ancelus SaaS software.
The 90-day period will allow companies to integrate and begin using the high-speed, high-capacity data software with little-to-no risk exposure and potentially advance existing combinatorial research in rapid fashion.
“The Ancelus data management system holds the proven performance to handle trillion row complex tables in nanoseconds,” said Morris. “The technology’s capacity to manage complex data structures makes it a superb foundational research tool for automated methods for reaction design, information management, chemical synthesis, compound analysis, and biological testing.”
Globally operational in healthcare and complex automated manufacturing for more than a decade, the new cloud-based version of the proven and patented AncelusDB data management system can be immediately implemented by synthetic chemistry laboratories and biotech operations engaged in COVID19 research. The new version – the Series JL5000 Ancelus SaaS system – is powered by the fastest in-market core AncelusDB database, independently benchmarked faster by many orders of magnitude than any other data technology available.
“The life sciences companies who currently use automated combinatorial chemistry methods generally leverage data management tech to accelerate research to discover potential disease treatments,” Morris noted. “But even with standard automated database technology it can takes months, even years to identify a compound with efficacy against a disease or pathogen.”
“The good news is that the high-speed Ancelus data management system can accelerate processes to the point where considerable advances can be made in days and weeks instead of months or years,” Morris continued. “Accordingly, by fast-tracking data-driven research through Ancelus SaaS software, a novel treatment for COVID-19 could potentially be achieved much more rapidly than by conventional data management systems.”
Series JL5000 Ancelus cloud-based SaaS software achieves its astonishing high-speed capacity and accuracy by eliminating the data duplication of traditional systems, achieving up to 20:1 data compression. The in-memory Ancelus system eliminates the channel bandwidth constraint with massively parallel access to a Single Logical Image with constant performance up to 16 Exabytes (16 billion gigabytes).
“Because of the unique interface for the Ancelus SaaS software, operational research platforms can be up and running within hours of installation,” Morris said. “Legacy database systems or SQL applications can be integrated into Ancelus with a minimum of disruption.”
As part of this unique offer to synthetic laboratories and related research operations, Ancelus will provide a set program of hands-on installation and real-time data management support to reduce integration time.
Serious inquiries by qualified companies or individuals can be made directly to John Morris. Performance data and benchmarks for the Ancelus SaaS product are available at www.ancelus.com
# # #
ABOUT ANCELUS
Ancelus software applications presently run telecom, advanced manufacturing and other businesses, some on a global basis at several facilities. The cloud-based Series JL5000 Ancelus SaaS software transforms a half-century of data management with rapid deployment, easy (virtually risk-free) integration, fast operation, low cost and extreme reliability, offering 100% uptime. For more information, please visit www.ancelus.com. Contact Michael Snyder at MEK for media information.